Recombinant peptide production using a cross-linkable solubility tag
View Patent ↗The invention relates to the recombinant expression of a peptide of interest in the form of a fusion protein comprising a solubility tag. The fusion protein comprises at least two portions separated by a cleavable peptide sequence wherein one portion is devoid of cysteine residues and the second portion comprises an effective number of cross-linkable cysteine residues. After cell lysis and isolation of the fusion protein, the fusion protein is subsequently cleaved into a mixture of first and second portions. Oxidative cross-linking is used to selectively precipitate one of the two portions to facilitate simple and effective separation of the peptide of interest.
1. A process to obtain a peptide of interest from a fusion peptide comprising:
a) providing a population of fusion peptides comprising the general structure:
IBT-CS-POI
or
POI-CS-IBT
wherein;
i) IBT is an inclusion body tag that does not include a cysteine residue;
ii) CS is a cleavage site; and
iii) POI is a peptide of interest comprising an effective number of cysteine residues;
b) cleaving the population of fusion peptides at said cleavage site whereby the inclusion body tag is no longer linked to the peptide of interest and whereby a mixture of peptide molecules is produced comprising a plurality of inclusion body tags and a plurality of peptides of interest;
c) subjecting the mixture of peptide molecules of step (b) to oxidizing conditions whereby the peptides of interest are cross-linked; and
d) recovering the peptide of interest.
2. A process according to claim 1 wherein the population of fusion peptides is produced in a recombinant host cell comprising a nucleic acid molecule encoding said fusion peptides.
3. The process of claim 1 wherein the effective number of cysteine residues in the peptide of interest is at least 3.
4. The process of claim 1 or 3 wherein the population of fusion peptides is cleaved by a cleavage reagent selected from the group consisting of chemical cleavage reagents and enzymatic cleavage reagents.
5. The process of claim 4 wherein the chemical cleavage reagent is an effective amount of an acid cleavage reagent.
6. The process of claim 1 wherein inclusion body tag is less than 125 amino acids in length.
7. The process of claim 1 wherein the peptide of interest is less than 300 amino acids in length.
8. The process of claim 7 wherein the peptide of interest is selected from the group consisting of body surface-binding peptides, hair-binding peptides, skin-binding peptides, nail-binding peptides, teeth-binding peptides, cellulose-binding peptides, polymer-binding peptides, clay-binding peptides, pigment-binding peptides, and antimicrobial peptides.
9. The process of claim 2 wherein the recombinant host cell is a microbial host cell.
10. The process of claim 9 wherein the microbial host cell is selected from the group consisting of bacteria, fungi, and yeast.
11. The process of claim 10 wherein the microbial host cell is selected from the group consisting of Aspergillus, Trichoderma, Saccharomyces, Pichia, Yarrowia, Candida, Hansenula, Salmonella, Bacillus, Acinetobacter, Zymomonas, Agrobacterium, Erythrobacter, Chlorobium, Chromatium, Flavobacterium, Cytophaga, Rhodobacter, Rhodococcus, Streptomyces, Brevibacterium, Corynebacteria, Mycobacterium, Deinococcus, Escherichia, Erwinia, Pantoea, Pseudomonas, Sphingomonas, Methylomonas, Methylobacter, Methylococcus, Methylosinus, Methylomicrobium, Methylocystis, Alcaligenes, Synechocystis, Synechococcus, Anabaena, Thiobacillus, Methanobacterium, Klebsiella , and Myxococcus.
12. The process of claim 1 wherein the oxidizing conditions comprises the presence of a gas comprising an effective amount of diatomic or triatomic oxygen.